Sitarest D Tablets – Sitagliptin 100mg Dapagliflozin 10mg Tablets Manufacturer, Supplier, Franchise In India

Sitarest D Tablets are an advanced oral antidiabetic combination formulated for the effective management of type 2 diabetes mellitus. This dual-therapy tablet combines Sitagliptin 100 mg, a DPP-4 inhibitor, with Dapagliflozin 10 mg, an SGLT2 inhibitor, offering comprehensive blood glucose control through complementary and insulin-independent mechanisms. Sitarest D is especially beneficial for patients who require improved glycemic control along with added cardiovascular and renal benefits.

Type 2 diabetes is a progressive metabolic disorder often associated with obesity, hypertension, and cardiovascular risk. Sitarest D targets multiple pathways involved in glucose regulation. Sitagliptin enhances the body’s natural incretin system to improve insulin secretion and reduce glucagon levels, while Dapagliflozin promotes the elimination of excess glucose through urine. Together, they provide effective control of fasting and postprandial blood glucose with a low risk of hypoglycemia.

Key Benefits of Sitagliptin 100mg Dapagliflozin 10mg Tablets

Dual-mechanism blood sugar control
Low risk of hypoglycemia when used appropriately
Helps reduce body weight
Improves insulin efficiency without overstimulation
Provides cardiovascular and kidney protective benefits
Convenient once-daily dosing improves compliance